Is lymph vascular space involvement an independent prognostic factor in early cervical cancer?

Gynecologic Oncology

Volumn 92, Issue 2, 2004, Pages 525-529

  Creasman, William T ^a   Kohler, Matthew F ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Cervical cancer; Lymph vascular space involvement; Prognostic factor

Indexed keywords

CANCER STAGING; CANCER SURGERY; EVALUATION; FEMALE; GYNECOLOGIC CANCER; HUMAN; LITERATURE; LYMPH NODE; LYMPH NODE METASTASIS; MULTIVARIATE ANALYSIS; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; PROGNOSIS; RADICAL HYSTERECTOMY; REVIEW; RISK FACTOR; SOCIOECONOMICS; TUMOR VOLUME; UTERINE CERVIX CANCER;

EID: 0842332174     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2003.11.020     Document Type: Review

References (34)

1. Annual Report on the Results of Treatment in Gynecological Cancers. J. Epidemiol. Biostat. 6:2001;45-86.
2. Annual Report on the Results of Treatment in Gynecological Cancers. J. Epidemiol. Biostat. 6:2001;5-44.
3. Friedell G.H., Parson L. The spread of cancer of the uterine cervix as seen in giant histological sections. Cancer. 1961;14-42.
4. Friedell G.H., Steiner G., Kistner R.W. Prognostic value of blood-vessel invasion in cervical cancer. Obstet. Gynecol. 29:1967;855-857.
5. Roche W.D., Norris H.J. Microinvasive carcinoma of the cervix: the significance of lymphatic invasion and confluent patterns of stromal growth. Cancer. 36:1975;180-186.
6. Benedet J.L., Anderson G.H. Stage IA carcinoma of the cervix revisited. Obstet. Gynecol. 87:1996;1052-1059.
7. Östör A.G. Studies on 200 cases of early squamous cell carcinoma of the cervix. Int. J. Gynecol. Pathol. 12:1993;193-207.
8. Graflund M., Sorbe B., Bryne M., Karlsson M. The prognostic value of histologic grading system, DNA profile, and MIB-1 expression in early stages of cervical squamous carcinoma. Int. J. Gynecol. Cancer. 12:2002;149-157.
9. Lai C.H., Hsueh S., Hong J.H., Chang T.C.et al. Are adenocarcinoma and adenosquamous carcinoma different from squamous carcinoma in Stage IB and II cervical cancer patients undergoing primary radical surgery. Int. J. Gynecol. Cancer. 9:1999;28-36.
10. Obermair A., Wanner C., Bilgi S., Speiser P.et al. Tumor angiogenesis in stage IB cervical cancer: correlation of microvessel density with survival. Am. J. Obstet. Gynecol. 17:1998;314-319.
11. Duk J.M., Groenier K.H., de Bruijn H.W., Hollema H.et al. Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma. J. Clin. Oncol. 14:1996;1118.
12. Hellebrekers B.W., Zwinderman A.H., Kenter G.G., Peters A.A.et al. Surgically-treated early cervical cancer: prognostic factors and the significance of depth of tumor invasion. In. J. Gynecol. Cancer. 9:1999;212-219.
13. Kim S.M., Choi H.S., Byun J.S. Overall 5year survival rates and prognostic factors in patients with Stage IB and IIA cervical cancer treated by radical hysterectomy and pelvic lymph node dissection. In. J. Gynecol. Cancer. 10:2000;305-312.
14. Trattner M., Graf A.H., Lax S., Forstner R.et al. Prognostic factors in surgically treated stage IB-IIB cervical carcinomas with special emphasis on the importance of tumor volume. Gynecol. Oncol. 82:2001;11-16.
15. Tsai C.S., Lai C.H., Wang C.C., Chang J.T.et al. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy. Gynecol. Oncol. 75:1999;328-333.
16. Finan M.A., DeCesare S., Fiorica J.V., Chambers R. Radical hysterectomy for Stage IB1 vs. IB2 carcinoma of the cervix. Gynecol. Oncol. 62:1996;139-147.
17. Dawlatly B., Laire O., Cross P.A., Iami M.et al. Prognostic factors in surgically-treated stage IB-IIB squamous cell carcinoma of the cervix with positive lymph nodes. Int. J. Gynecol. Cancer. 8:1998;467-470.
18. Kristensen G.B., Abeler V.M., Risberg B., Trop C.et al. Tumor size depth of invasion, and grading of invasive tumor front are the main prognostic factors in early squamous cell carcinoma. Gynecol. Oncol. 74:1999;245-251.
19. Gauthier P., Gore I., Shingleton H.M., Soong S.J.et al. Identification of histopathologic risk groups in Stage IB squamous cell carcinoma of the cervix. Obstet. Gynecol. 66:1985;569-574.
20. Kamura T., Tsukamoto N., Tsuruchi N., Saito T.et al. Multivariate analysis of histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy. Cancer. 69:1992;181-186.
21. Kainz C.H., Gitsch G., Tempfer C., Heinzl H.et al. Vascular space invasion and inflammatory stroma reaction as prognostic factors in patients with surgically treated cervical cancer stage IB to IIB. Anticancer Res. 14:1994;2245-2448.
22. Samlal R.A.K., van der Velden J., Ten Kate F.J.et al. Surgical pathologic factors that predict recurrence in Stage IB and IIA carcinoma patients with negative pelvic lymph nodes. Cancer. 80:1997;1234-1240.
23. Yuan C.C., Wang P.H., Lai C.R., Yen M.S.et al. Prognosis-predicting system based on factors related to survival of cervical carcinoma. Int. J. Gynecol. Obstet. 63:1998;163-167.
24. Snijders-Keilholz A., Hellebrekers B.W.Z., Swinderman A.H., van de Vijver M.Jet al. Adjuvant radiotherapy following radical hysterectomy for patients with early-staged cervical carcinoma. Radiother. Oncol. 51:1999;161-167.
25. Aoki Y., Sasaki M., Watanabe M., Sato T.et al. High risk group in node-positive patients with Stage IB, IIA, IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation. Gynecol. Oncol. 77:2000;305-309.
26. Burghardt E., Baltzer J., Tulusan A.H., Haas J. Results of surgical treatment of 1028 cervical cancers studied with volumetry. Cancer. 70:1992;648-655.
27. Kamura T., Tsukamoto N., Tsurichi N., Kaku T.et al. Histopathologic prognostic factors in stage IIB cervical carcinoma treated with radical hysterectomy and pelvic node dissection. Int. J. Gynecol. Cancer. 3:1993;219-225.
28. Hopkins M.P., Morley G.W. Stage IB squamous cell cancer of the cervix: clinicopathologic features related to survival. J. Obstet. Gynecol. 164:1991;1520-1529.
29. Yuan C.C., Wang P., Lai C.R., Tsu E.et al. Recurrence and survival analysis of 1115 cervical cancer patients treated with radical hysterectomy. Gynecol. Obstet. Invest. 47:1999;127-132.
30. Frigerio L., Mariani A., Gandini L., Origoni M.et al. Prognostic factors in patients with locally advanced cervical cancer treated with radical hysterectomy and adjuvant radiotherapy. Int. Surg. 83:1998;265-270.
31. Kenter G.G., Ansink A.C., Heintz A.P., Delemarre J.et al. Low stage invasive carcinoma of the uterine cervix stage I-IIA morphological prognostic factors. Eur. J. Surg. Oncol. 14:1988;187-192.
32. Atasii T., Asku M.F., Cetinkaya M.P. Prognostic factors that affect survival after the treatment of the early stage cervical carcinoma. Int. Surg. 85:2000;147-151.
33. Burghardt E., Girardi F., Lahousen M., Pickel H.et al. Microinvasive carcinoma the uterine cervix. Cancer. 67:1991;1037-1045.
34. Girardi F., Burghardt E., Pickel H. Small FIGO stage IB cervical cancer. Gynecol. Oncol. 55:1994;427-432.